Hamidreza Ghasemirad | Medicine and Dentistry | Young Researcher Award

Published on by Invention Awards

Young Researcher Award

Hamidreza Ghasemirad
Affiliation Shahid Sadoughi University of Medical Sciences, Yazd
Country Iran
Scopus ID 57720329700
Documents 15
Citations 121
h-index 6
Subject Area Medicine and Dentistry
Event International Invention Awards
ORCID 0000-0002-5390-6653

Hamidreza Ghasemirad

Shahid Sadoughi University of Medical Sciences, Yazd, Iran

Hamidreza Ghasemirad is an emerging researcher affiliated with Shahid Sadoughi University of Medical Sciences, Yazd, whose scholarly activities primarily focus on medicine and dentistry. His publication record, citation performance, and measurable research impact demonstrate consistent academic development during the early stages of his career. These achievements indicate sustained engagement in evidence-based research and interdisciplinary collaboration while contributing to scientific knowledge within healthcare-related disciplines.[1]

Abstract

Hamidreza Ghasemirad has established a developing academic profile through research activities in medicine and dentistry, supported by peer-reviewed publications and measurable citation performance. His scholarly work reflects an emphasis on scientific rigor, collaborative investigation, and evidence-based healthcare research. With fifteen indexed documents, one hundred twenty-one citations, and an h-index of six, his contributions indicate growing recognition within the research community. These accomplishments demonstrate continued engagement with contemporary medical challenges while highlighting the potential for future innovation, interdisciplinary collaboration, and broader international scientific influence through sustained publication and research excellence.[1][2]

Keywords

Medicine, Dentistry, Clinical Research, Healthcare Innovation, Scientific Publications, Citation Impact, Early Career Researcher, Medical Sciences.

Introduction

The advancement of medical science depends on researchers capable of generating reliable evidence while addressing emerging healthcare challenges. Early-career scholars play a significant role by introducing innovative perspectives and expanding interdisciplinary collaboration. Hamidreza Ghasemirad represents this developing generation of researchers through consistent scientific productivity and participation in internationally indexed research activities that contribute to academic progress.[2]

Research Profile

Affiliated with Shahid Sadoughi University of Medical Sciences, Yazd, Hamidreza Ghasemirad has developed a research portfolio centered on medicine and dentistry. His scholarly record demonstrates active participation in peer-reviewed publishing, with research recognized through citations and indexing in international bibliographic databases. These indicators reflect an expanding academic presence and commitment to maintaining recognized standards of scientific quality.[1]

Research Contributions

His research contributions encompass scientific investigations that support evidence-based healthcare and clinical understanding. Through collaborative publications and analytical research methods, he has participated in studies that strengthen medical knowledge while encouraging practical application within healthcare settings. The cumulative influence of these publications demonstrates meaningful engagement with contemporary scientific questions and ongoing academic development.[3]

Publications

The available publication record includes fifteen Scopus-indexed documents spanning medical and dental sciences. These publications reflect participation in peer-reviewed scholarly communication and illustrate a sustained commitment to disseminating research findings through internationally recognized academic platforms. Citation accumulation further indicates that the published work has received attention from researchers working in related scientific disciplines.[1][4]

Research Impact

Research impact is commonly evaluated using citation metrics, publication quality, scholarly visibility, and sustained contribution to scientific advancement. Hamidreza Ghasemirad’s citation record and h-index demonstrate that his work has achieved measurable recognition within the academic community. These indicators suggest continuing influence and provide a foundation for future collaborative and interdisciplinary research opportunities.[2]

Award Suitability

Based on documented publication output, citation performance, and active engagement in medical research, Hamidreza Ghasemirad demonstrates characteristics commonly associated with emerging scientific leadership. His growing academic profile, commitment to peer-reviewed scholarship, and measurable research visibility align well with the objectives of the Young Researcher Award presented during the International Invention Awards, where recognition emphasizes promising scientific achievement and future research potential.[5]

Conclusion

Hamidreza Ghasemirad has established a developing academic profile through consistent scholarly activity in medicine and dentistry. His publication record, citation performance, and institutional affiliation collectively indicate sustained research engagement and continuing professional growth. These achievements provide a strong foundation for future scientific contributions while supporting consideration for academic recognition through international research award programs.[1]

External Links

References

  1. Elsevier. (n.d.). Scopus Author Details: Hamidreza Ghasemirad, Author ID 57720329700. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=57720329700
  2. ORCID. (n.d.). ORCID Record: Hamidreza Ghasemirad.
    https://orcid.org/0000-0002-5390-6653
  3. Pharmaceutical and Biomedical Research. (2025). Clinical and Prognostic Findings in Psychotropic Substance Poisoning: A Cross-sectional Study.
    https://doi.org/10.32598/pbr.11.3.1366.1
  4. Molecular and Cellular Biochemistry. (2023). The circadian clock as a potential biomarker and therapeutic target in pancreatic cancer.
    https://doi.org/10.1007/s11010-023-04790-4
  5. International Invention Awards. (n.d.). Award Information and Recognition Program.
    https://inventionawards.org/

Carlos Escobar | Medicine and Dentistry | Best Researcher Award- 25576

Published on by Invention Awards

Prof. Dr. Carlos Escobar | Medicine and Dentistry | Best Researcher Award

Prof. Dr. Carlos Escobar | Hospital La Paz, Madrid | Spain

Dr. Carlos Escobar Cervantes is a leading cardiologist and researcher based in Madrid, Spain. With over two decades of experience in cardiovascular medicine, he has held esteemed roles in top Spanish hospitals, contributed prolifically to scientific literature, and has played leadership roles within major cardiology societies. He currently serves as Facultativo Adjunto del Servicio de Cardiología at Hospital Universitario La Paz and is the Scientific Director of the Consorcio DTX, focusing on digital therapeutics (DTx) and AI in health. His work bridges clinical expertise and digital innovation, making him a pioneer in the integration of artificial intelligence in cardiovascular care. Dr. Escobar’s dedication extends beyond patient care—he is also a respected academic and educator, shaping future medical professionals. His contribution to cardiovascular pharmacology, hypertension, ischemic heart disease, and public health through clinical trials, publications, and professional society work makes him an exemplary candidate for international recognition.

Profile

Scopus

Education

Dr. Carlos Escobar Cervantes earned his Medical Degree in Medicine and Surgery from the Universidad Autónoma de Madrid (1993–1999). He pursued academic excellence and scientific inquiry further by completing a PhD in Medicine at the Universidad de Alcalá in 2007, where he was awarded the prestigious distinction of Sobresaliente Cum Laude, by unanimous decision of the examining board. This rigorous academic path provided him with a strong foundation for his career in internal medicine, clinical cardiology, and scientific research. Additionally, his commitment to academic growth is reflected in his successful qualification as a Profesor Ayudante Doctor recognized by ANECA in June 2011. Further enriching his academic and leadership portfolio, Dr. Escobar completed the Leadership Development Program in Public Healthcare Organizations from ESADE Business School (2011–2012), one of Spain’s most prestigious business institutions. His education uniquely combines clinical, scientific, and managerial expertise—vital for innovative cardiovascular leadership.

Professional Experience

Dr. Escobar Cervantes has held successive and prestigious roles in cardiology across some of Madrid’s foremost healthcare institutions. He began his career as a Médico Adjunto de Cardiología at Hospital Universitario Ramón y Cajal (2006–2008), then transitioned to Hospital Universitario Infanta Sofía (2008–2012), and has been serving at Hospital Universitario La Paz since 2012. Currently, he also coordinates outpatient cardiology services and care continuity at La Paz, a role he took on in June 2023, showcasing his capacity for healthcare system organization and innovation. Since December 2023, Dr. Escobar has been the Scientific Director of the Consorcio DTX, focused on the application of digital health tools, including AI, in cardiology. He is also the Co-founder of Samira DTX, emphasizing his proactive stance in developing evidence-based digital therapeutic solutions. His career represents a seamless integration of bedside excellence, scientific leadership, and organizational impact in Spanish and international cardiology.

Research Interests

Dr. Escobar’s research focuses on ischemic heart disease, arterial hypertension, atrial fibrillation, and pulmonary thromboembolism. As both principal investigator and co-investigator, he has played key roles in clinical trials exploring innovative therapies in these domains. In recent years, he has expanded his research to encompass digital therapeutics (DTx) and the application of artificial intelligence (AI) in cardiovascular medicine. He is an active contributor to the Sociedad Española de Cardiología (SEC) and the European Society of Cardiology, where he is a member of the cardiovascular pharmacology and hypertension working groups. His research is deeply translational—bringing bench-side developments to bedside application. His commitment to improving cardiovascular care outcomes through technological innovation, patient-centered care models, and robust clinical investigation underscores his status as a forward-thinking leader in cardiovascular science. Dr. Escobar’s dual commitment to both scientific discovery and clinical impact has made him a valued voice in the cardiology research community.

Awards and Professional Recognition

Dr. Carlos Escobar is a highly respected figure in cardiology, having served as President of the Clinical Cardiology Section of the Sociedad Española de Cardiología (SEC). He has been a member of the SEC’s Research Agency and is an active contributor to several working groups under both SEC and the European Society of Cardiology (ESC). His academic and research contributions have earned him memberships in international editorial boards such as the World Journal of Hypertension, ISRN Nephrology, and the Journal of Cardiology and Therapeutics. His peer-review activity includes esteemed journals like Annals of Internal Medicine, Diabetes Care, and the Journal of Hypertension, reflecting his reputation as an authority in cardiovascular science. These honors reflect a career distinguished not only by scientific productivity but also by community trust and professional excellence. His leadership, publications, and collaborative spirit make him a worthy nominee for high-level international awards.

Publications

Cost-utility analysis of dapagliflozin for the treatment of symptomatic chronic heart failure in Spain

The gut microbiota and its role in the development of cardiovascular disease

Management of children with heterozygous familial hypercholesterolaemia worldwide: a meta-analysis

Artificial intelligence: a promising tool for the clinical cardiologist

Magnitude of chronic kidney disease in Spain

Conclusion

Dr. Carlos Escobar Cervantes exemplifies the union of clinical excellence, academic integrity, and technological foresight. His contributions to cardiology span groundbreaking clinical research, digital health innovation, and transformative educational leadership. His work has directly improved cardiovascular care standards in Spain and beyond, earning him recognition across editorial boards, societies, and digital medicine consortia. Dr. Escobar is not only a scientific leader but also an innovator, teacher, and strategist, positioning him as a well-rounded and future-focused candidate for any top-tier international medical or scientific award. His pioneering initiatives in AI-driven cardiovascular therapeutics, combined with his extensive academic publications and clinical leadership, embody the spirit of 21st-century medical excellence. He is therefore highly recommended for recognition in awards celebrating innovation, excellence, and translational impact in cardiovascular medicine.